Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/(sici)1097-0142(19990815)86:4<730::aid-cncr26>3.0.co;2-p | DOI Listing |
Publication Analysis
Top Keywords
author reply
4
author
1
Similar Publications
Complete response to mTOR inhibitor following JAKi failure in severe pulmonary sarcoidosis: Authors' reply.
Pulmonology
December 2025
AP-HP, Pulmonology Department, Avicenne Hospital, Bobigny, France.
Author's Reply to Liu et al.: "A Prospective Longitudinal Study of the Effects of Eslicarbazepine Acetate Treatment on Bone Density and Metabolism in Patients with Focal‑Onset Epilepsy".
CNS Drugs
January 2025
Faculty of Medicine, Epilepsy Center, University of Freiburg, Breisacherstr. 64, 79106, Freiburg, Germany.
Reply to: Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies.
Nat Commun
January 2025
Research Division, Autolus Therapeutics, London, UK.
Extra-articular manifestations in rheumatoid arthritis: Incidence and predisposing factors. Author's reply.
Eur J Intern Med
January 2025
Department of Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå, Sweden. Electronic address:
Authors' reply: "Effect of colistin combined with sulbactam: 9 g versus 12 g per day on mortality in the treatment of carbapenems resistant Acinetobacter baumannii pneumonia: a randomized controlled trial".
Int J Infect Dis
January 2025
Division of Infectious Disease, Department of Medicine, Phramongkutklao Hospital, Bangkok, Thailand.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!